We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Presents High-Quality Hematology and Clinical Chemistry Products

By LabMedica International staff writers
Posted on 29 Jul 2025

Diatron (Budapest, Hungary) is exhibiting at ADLM 2025, where the company is presenting its newly launched clinical chemistry analyzer alongside other high-quality hematology products. More...

Diatron’s new clinical chemistry analyzer, the P780, which is being introduced at the show, is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories. Ideal for a variety of lab sizes, from medium to large, the P780 is engineered for high reliability, offering an innovative and scalable solution. As Diatron’s flagship clinical chemistry analyzer, the P780 excels in maximum throughput, which is enabled by uninterrupted photometric tests and an independent ISE arm. As a result, the P780 allows continuous operation under demanding workloads, ensuring fast turnaround times without compromising accuracy. The system is equipped with a dual concentric reagent tray with cooled positions for calibrators and controls, plus an optional Auto Filling Draining Module that enables nonstop operation and reduces manual work.

A built-in panel PC with a touchscreen interface helps to minimize the instrument’s footprint and streamline daily use. The system features advanced software, delivering an intuitive, easy-to-use interface and a comprehensive dashboard, with real-time worklist monitoring and flexible workflow management tools to simplify daily lab procedures. Diatron is also showcasing Aquila, its innovative and revolutionary 3-part differential hematology analyzer that can be used in any testing location and application where high-quality CBC results are desired. The company’s latest technology offers the optimal testing solution for both the experienced and inexperienced user, and practices that require a high-quality hematology analyzer.

Diatron is also highlighting its Aquarius 3 hematology analyzer that combines technology and simplicity to give all the required information, reducing the unnecessary steps to a minimum whilst maintaining the balance between cost and benefit for patients and users alike. With a sleek, new modern design, the Aquarius 3 interface offers a positive touch and feeling, with all actions designed to increase efficiency, saving time to perform other important tasks. The new Aquarius 3 software features a high level of patient management and workflow optimization to avoid repetition whilst only having a small reagent consumption.

Related Links:
Diatron


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.